US4634677AExpiredUtility
Plasmid capable of expressing human growth hormone
Est. expiryJul 5, 1999(expired)· nominal 20-yr term from priority
C12N 15/62C07K 2319/00C07K 2319/02C07K 2319/50C12N 15/70C12N 15/10C07K 14/61Y10S930/12C07K 2319/75C12N 15/66C12P 21/02C12N 15/00C12R 2001/19C12N 1/205
91
PatentIndex Score
55
Cited by
68
References
7
Claims
Abstract
Described are methods and means for the construction and microbial expression of quasi-synthetic genes arising from the combination of organic synthesis and enzymatic reverse transcription from messenger RNA sequences incomplete from the standpoint of the desired protein product. Preferred products of expression lack bio-inactivating leader sequences common in eukaryotic expression products but problematic with regard to microbial cleavage to yield bioactive material. Illustrative is a preferred embodiment in which a gene coding for human growth hormone (useful in, e.g., treatment of hypopituitary dwarfism) is constructed and expressed.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A replicable bacterial plasmid which, in a transformant bacterium, will express a gene for human growth hormone unaccompanied by the human growth hormone leader sequence or other extraneous protein bound thereto.
2. A plasmid according to claim 1 whose human growth hormone-encoding gene comprises in substantial proportion cDNA or a replication thereof.
3. A plasmid according to claim 2 which exhibits resistance to at least one antibiotic.
4. A plasmid according to claim 3 which lacks the tet promoter yet exhibits tetracycline resistance.
5. A plasmid according to claim 4 in which the human growth hormone-encoding gene is under the control of tandem lac promoters.
6. The plasmid pHGH107.
7. The plasmid pHGH107-1.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.